Literature DB >> 17978154

Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?

T M Maher1, A U Wells, G J Laurent.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a devastating condition that carries a prognosis worse than that of many cancers. A recent classification of the idiopathic interstitial pneumonias has redefined the diagnostic criteria necessary to determine a diagnosis of IPF. The present authors believe that this redefinition is incorrect, relying as it does on subtle histological differences for the definition of separate disease categories. A further issue affecting IPF research is the polarisation of views around two competing pathogenetic hypotheses. One argues for the primacy of inflammation as the trigger that initiates fibrosis, and the other proposes that fibrosis arises as a consequence of chronic epithelial injury and failure of repair due to aberrant epithelial-mesenchymal interactions. The present authors believe that this schism is hampering understanding of IPF and skewing research priorities. It is argued here, instead, that abnormalities in multiple pathways involved in wound healing and inflammation lead to the development of idiopathic pulmonary fibrosis, and it is suggested that a new rationale for clinical classification and pathogenesis may be more productive in driving the search for novel therapies in the future.

Entities:  

Mesh:

Year:  2007        PMID: 17978154     DOI: 10.1183/09031936.00069307

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  98 in total

1.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

Review 2.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

3.  Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro.

Authors:  Ulrike Carolin Müller-Quernheim; Lars Potthast; Joachim Müller-Quernheim; Gernot Zissel
Journal:  J Interferon Cytokine Res       Date:  2012-01-26       Impact factor: 2.607

4.  miR-29 is a major regulator of genes associated with pulmonary fibrosis.

Authors:  Leah Cushing; Ping Ping Kuang; Jun Qian; Fengzhi Shao; Junjie Wu; Frederic Little; Victor J Thannickal; Wellington V Cardoso; Jining Lü
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-22       Impact factor: 6.914

Review 5.  Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.

Authors:  Casimiro Gerarduzzi; John A Di Battista
Journal:  Inflamm Res       Date:  2016-12-31       Impact factor: 4.575

6.  Smoking-related idiopathic interstitial pneumonia.

Authors:  Kevin R Flaherty; Charlene Fell; Marie-Christine Aubry; Kevin Brown; Thomas Colby; Ulrich Costabel; Teri J Franks; Barry H Gross; David M Hansell; Ella Kazerooni; Dong Soon Kim; Talmadge E King; Masanori Kitachi; David Lynch; Jeff Myers; Sonoko Nagai; Andrew G Nicholson; Venerino Poletti; Ganesh Raghu; Moises Selman; Galen Toews; William Travis; Athol U Wells; Robert Vassallo; Fernando J Martinez
Journal:  Eur Respir J       Date:  2014-07-25       Impact factor: 16.671

7.  Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.

Authors:  Khondoker M Akram; Nicola J Lomas; Nicholas R Forsyth; Monica A Spiteri
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

8.  Treating CTDs related fibrotic ILDs by immunosuppressants: "facts and faults".

Authors:  Spyros A Papiris; Konstantinos Kagouridis; Georgia Papadaki; Likurgos Kolilekas; Effrosyni D Manali
Journal:  Lung       Date:  2013-11-12       Impact factor: 2.584

Review 9.  High-resolution computed tomography in the diagnosis and follow-up of idiopathic pulmonary fibrosis.

Authors:  N Sverzellati; M De Filippo; T Bartalena; S Piciucchi; M Zompatori
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

10.  Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.

Authors:  Priya Kulasekaran; Casey A Scavone; David S Rogers; Douglas A Arenberg; Victor J Thannickal; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.